Announcements & Circulars-Alphamab Oncology

English 中文简体中文繁体

English 中文简体中文繁体

Investors

Information Disclosure

Listing Documents

Financial Reports

Announcements & Circulars

Company Presentation

Corporate Governance

Stock Information

Corporate Communications

Email Subscription

Announcements & Circulars

The announcement begins in December 2019

Terms of Reference of the Remuneration Committee 2022-12-28
VOLUNTARY ANNOUNCEMENT - PRESENTATION OF RESEARCH UPDATES ON KN046 AND KN026 AT THE SABCS 2022 2022-12-09
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022 2022-12-06
Next Day Disclosure Return 2022-11-24
Next Day Disclosure Return 2022-11-16
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022 2022-11-04
VOLUNTARY ANNOUNCEMENT - IND APPROVAL BY NMPA FOR A PHASE IA/IB CLINICAL TRIAL OF JSKN003 FOR THE TREATMENT OF ADVANCED SOLID TUMORS 2022-10-27
GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME 2022-10-24
GRANT OF SHARE OPTIONS 2022-10-24
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2022 2022-10-05

9 10 11 12 13 14 15